Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study

Abstract

Background: Isoflavones are estrogen-like plant compounds that may protect against cardiovascular disease and endocrine-responsive cancer. Isoflavones may, because of their ability to act as selective estrogen receptor modulators, alter insulin-like growth factor (IGF) status.

Objective: The aim of this study was to assess the effect of 1-month isoflavone supplementation (86 mg/day red clover-derived isoflavones) on IGF status.

Design and subjects: Healthy pre- (n=16) and postmenopausal (n=7) women were invited to take part in a randomised, placebo-controlled crossover study with a minimum 2-month washout period.

Results: For premenopausal subjects, the change in IGF-1, IGF-BP1 and IGF-BP3 assessed at different points of the menstrual cycle did not differ between isoflavone and placebo phase. However, the change in IGF-1, when examined pre- and post-supplementation, was nonsignificantly reduced (P=0.06) on the isoflavone supplement compared to placebo. For postmenopausal subjects, the change in IGF-1, IGF-BP1 and IGFBP-3 concentrations over the supplementation period did not differ between isoflavone or placebo phase. Isoflavones increased HDL in postmenopausal women compared to placebo (P=0.02) but did not alter either cholesterol or triacylglycerol concentrations, and had no effect on antioxidant status.

Conclusions: This study shows that 1-month supplementation with red clover isoflavones has a positive effect on HDL cholesterol, but at most a small effect on IGF status in premenopausal and no effect in postmenopausal subjects. Further studies are required to ascertain the role these dietary compounds may have to play in breast cancer prevention.

Sponsorship: The isoflavone and placebo supplements were kindly supplied by Novogen (North Ryde, Sydney, Australia). This study was supported by Action Against Breast Cancer registered charity number 1020967.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Anderson JJB, Anthony M, Messina M & Garner SC (1999): Effects of phyto-estrogens on tissues. Nutr. Res. Rev. 12, 75–116.

    Article  CAS  Google Scholar 

  • Anderson JW, Johnstone BM & Cook-Newell ME (1995): Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 332, 276–282.

    Article  Google Scholar 

  • Aukema HM, Housini I (2001): Dietary soy protein effects on disease and IGF-1 in male and female Han:SPRD-cy rats. Kidney Int. 59, 52–61.

    Article  CAS  Google Scholar 

  • Bingham SA, Atkinson C, Liggins J, Bluck L & Coward A (1998): Phyto-estrogens: where are we now? Br. J. Nutr. 79, 393–406.

    Article  CAS  Google Scholar 

  • Campbell MJ, Woodside JV, Secker-Walker J, Titcomb A & Leathem AJC (2001): IGF status is altered by Tamoxifen in breast cancer patients. Mol. Pathol. 54, 307–310.

    Article  CAS  Google Scholar 

  • Clemmons DR & Underwood LE (1991): Nutritional regulation of IGF-1 and IGF binding proteins. Ann. Rev. Nutr. 11, 393–412.

    Article  CAS  Google Scholar 

  • Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML & Moreton T (2001): The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 8, 259–265.

    Article  CAS  Google Scholar 

  • Costa RL & Summa MA (2000): Soy protein in the management of hyperlipidemia. Ann. Pharmacother 34, 931–935.

    Article  CAS  Google Scholar 

  • Craft NE, Wise SA & Soares JH (1992): Optimisation of an isocratic high performance liquid chromatography separation of carotenoids. J. Chromatogr. 589, 171–176.

    Article  CAS  Google Scholar 

  • Hankinson SE, Willett WC, Colditz GA et al (1998): Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 1393–1396.

    Article  CAS  Google Scholar 

  • Helle SI, Anker G, Meadows KA et al (1998): Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas 28, 259–265.

    Article  CAS  Google Scholar 

  • Hodgson JM, Puddey IB, Croft KD, Mori TA, Rivera J & Beilin LJ (1999): Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure. Atherosclerosis 145, 167–172.

    Article  CAS  Google Scholar 

  • Howes JB, Sullivan D, Lai N et al (2000): The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152, 143–147.

    Article  CAS  Google Scholar 

  • Hsu C-S, Shen WW, Hsueh Y-M & Yeh S-L (2001): Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J. Reprod. Med. 46, 221–226.

    CAS  PubMed  Google Scholar 

  • Jenkins DJA, Kendall CWC, Vidgen E et al (2000): Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism 49, 1496–1500.

    Article  CAS  Google Scholar 

  • Juul A, Anker G, Pederson AT et al (1997): Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum. Reprod. 12, 2123–2128.

    Article  CAS  Google Scholar 

  • Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H & Gmeiner BMK (1997): Genistein, the dietary derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage from atherogenic LDL. Arterioscler. Thromb. Vasc. Biol. 17, 2868–2874.

    Article  CAS  Google Scholar 

  • Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME & Arjmandi BH (2002): Soy protein supplementation increases insulin-like growth factor-1 in young and old men but does not affect markers of bone metabolism. J. Nutr. 132, 2605–2608.

    Article  CAS  Google Scholar 

  • Knight DC, Howes JB & Eden JA (1999): The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 2, 79–84.

    Article  CAS  Google Scholar 

  • Lissin LW & Cooke JP (2000): Phytestrogens and cardiovascular health. J. Am. Coll. Cardiol. 35, 1403–1410.

    Article  CAS  Google Scholar 

  • McKeown NM, Day NE, Welch AA et al (2001): Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort. Am. J. Clin. Nutr. 74, 188–196.

    Article  CAS  Google Scholar 

  • Merz-Demlow BE, Duncan AM, Wangen KE et al (2000): Soy isoflavones improve plasma lipids in normocholesterolemic premenopausal women. Am. J. Clin. Nutr. 71, 1462–1469.

    Article  CAS  Google Scholar 

  • Morton MS, Wilcox G, Wahlqvist ML & Griffiths K (1994): Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142, 252–259.

    Article  Google Scholar 

  • Nestel PJ, Pomeroy S, Kay S et al (1999): Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 84, 895–898.

    CAS  Google Scholar 

  • Pollak M, Costantino J, Polychronakos C et al (1990): Effect of tamoxifen on serum insulin like growth factor-1 levels in stage I breast cancer patients. J. Natl. Cancer. Inst. 82, 1693–1697.

    Article  CAS  Google Scholar 

  • Potter SM (1995): Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J. Nutr. 125, S606–S611.

    Google Scholar 

  • Samman S, Lyons Wall PM, Chan GSM, Smith SJ & Petocz P (1999): The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147, 277–283.

    Article  CAS  Google Scholar 

  • Simons LA, von Konigsmark M, Simons J & Celermajer DS (2000): Phytestrogens do not influence lipoprotein levels or endothelial function in healthy postmenopausal women. Am. J. Cardiol. 85, 1297–1301.

    Article  CAS  Google Scholar 

  • Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N & Shimizu H (2000): Hypocholesterolemic effect of soy milk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev. Med. 31, 308–314.

    Article  CAS  Google Scholar 

  • This P, de al Rochefordiere A, Clough K, Fourquet A & Magfelenat H (2001): Phytestrogens after breast cancer. End Relat. Cancer 8, 129–134.

    Article  CAS  Google Scholar 

  • Tikkanen MJ, Wahala K, Ojala S, Vihma V & Adlercreutz H (1998): Effect of soybean phytestrogen intake on low density lipoprotein oxidation resistance. Pro. Natl. Acad. Sci. USA 95, 3106–3110.

    Article  CAS  Google Scholar 

  • Vuillemier JP & Keck E (1989): Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J. Micronut. Anal. 5, 25–34.

    Google Scholar 

  • Wangen KE, Duncan AM, Merz-Demlow BE et al (2000): Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 85, 3043–3048.

    CAS  Google Scholar 

  • Wiseman H, O'Reilly JD, Adlercreutz H et al (2000): Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72, 395–400.

    Article  CAS  Google Scholar 

  • Young IS & Trimble ER (1991): Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann. Clin. Biochem. 28, 504–508.

    Article  Google Scholar 

Download references

Acknowledgements

The isoflavone and placebo supplements were kindly supplied by Novogen (North Ryde, Sydney, Australia). This study was supported by Action Against Breast Cancer registered charity number 1020967.

Author information

Authors and Affiliations

Authors

Contributions

Guarantor: JV Woodside.

Contributors: MJ Campbell was involved in protocol design, sample analysis, interpretation of the findings and preparation of the manuscript, and carried out all the subject recruitment and sample processing. JV Woodside was involved in protocol design, sample analysis, statistical analysis, interpretation of the findings and preparation of the manuscript. JW Honour advised on the final stages of the protocol and was involved in the isoflavone analysis and in the interpretation of the study findings. MS Morton advised on the final stages of the protocol, directed the isoflavone analysis and was involved in the interpretation of the study findings. AJC Leathem advised on protocol development and preparation of the manuscript.

Corresponding author

Correspondence to J V Woodside.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campbell, M., Woodside, J., Honour, J. et al. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur J Clin Nutr 58, 173–179 (2004). https://doi.org/10.1038/sj.ejcn.1601764

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1601764

Keywords

This article is cited by

Search

Quick links